| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6794 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8867 |
| P-glycoprotein Substrate | Substrate | 0.7419 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6166 |
| Inhibitor | 0.9267 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6464 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4285 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6696 |
| CYP450 2D6 Substrate | Substrate | 0.7894 |
| CYP450 3A4 Substrate | Substrate | 0.6999 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8489 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.7872 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8455 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7788 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.7882 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5596 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8355 |
| Inhibitor | 0.7220 |
| AMES Toxicity | Non AMES toxic | 0.5609 |
| Carcinogens | Non-carcinogens | 0.6166 |
| Fish Toxicity | High FHMT | 0.9931 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8749 |
| Honey Bee Toxicity | Low HBT | 0.6832 |
| Biodegradation | Not ready biodegradable | 0.8010 |
| Acute Oral Toxicity | III | 0.5280 |
| Carcinogenicity (Three-class) | Non-required | 0.6116 |